Drug-Resistant Infections Surge Worldwide, Who Warns
The WHO’s latest report shows that from 2018 to 2023, antibiotic resistance surged in over 40% of the pathogen-antibiotic pairs monitored, with annual increases ranging between 5% and 15%. This alarming trend threatens the effectiveness of crucial antibiotics used to combat infections affecting the urinary tract, gastrointestinal system, bloodstream, and sexually transmitted diseases like gonorrhea.
Data compiled from more than 100 countries through the WHO’s Global Antimicrobial Resistance and Use Surveillance System highlight the accelerating spread of resistance to essential drugs.
"Antimicrobial resistance is outpacing advances in modern medicine, threatening the health of families worldwide," said WHO Director-General Tedros Adhanom Ghebreyesus.
The report identifies the highest resistance rates in the WHO South-East Asian and Eastern Mediterranean regions, where one in three infections is now drug-resistant. Particularly concerning are drug-resistant strains of E. coli and Klebsiella pneumoniae, leading causes of bloodstream infections, with over 50% of cases globally now impervious to first-line treatments.
The WHO called on nations to bolster laboratory capacity and improve the sharing of robust antimicrobial resistance data by 2030 to combat this escalating threat.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
